부산대학교 도서관

Trans. A. Razmadze Math. Inst. 178 (2024), 443-468

Schöpf, Julia; Uhrig, Sebastian; Heilig, Christoph E.; Lee, Kwang Seok; Walther, Tatjana; Carazzato, Alexander; Dobberkau, Anna Maria; Weichenhan, Dieter; Plass, Christoph; Hartmann, Mark; Diwan, Gaurav D.; Carrero, Zunamys I.; Ball, Claudia R.; Hohl, Tobias; Kindler, Thomas; Rudolph-Hähnel, Patricia; Helm, Dominic; Schneider, Martin; Nilsson, Anna; Øra, Ingrid; Imle, Roland; Banito, Ana; Russell, Robert B.; Jones, Barbara C.; Lipka, Daniel B.; Glimm, Hanno; Hübschmann, Daniel; Hartmann, Wolfgang; Fröhling, Stefan; Scholl, Claudia

Nature Communications. 15:1-17

William, D.; Bermúdez, M.; Kübler, A.; Kahlert, C.; Distler, M.; Weitz, J.; Uhrig, S.; Fröhlich, M.; Hutter, B.; Aust, D.; Baretton, G.; Wimberger, P.; Kast, K.; Meisel, C.; Gieldon, L.; Porrmann, J.; Wagner, J.; Arlt, M.; Franke, M.; Fischer, J.; Hackmann, K.; Kreutzfeldt, S.; Mock, A.; Heilig, C.E.; Lipka, D.B.; Teleanu, M.-V.; Schlenk, R.F.; Brors, B.; Hübschmann, D.; Paramasivam, N.; Richter, D.; Beck, K.; Pfütze, K.; Buchhalter, I.; Weichert, W.; Herold, T.; Spiekermann, K.; Jost, P.J.; Keilholz, U.; Klauschen, F.; Bauer, S.; Siveke, J.T.; Kindler, T.; Boerries, M.; Illert, A.L.; Bitzer, M.; Schulze-Osthoff, K.; Schirmacher, P.; Stenzinger, A.; Horak, P.; Heining, C.; Folprecht, G.; Fröhling, S.; Glimm, H.; Schröck, E.; Jahn, A.

ESMO Gastrointestinal Oncology. 9

Teleanu, M.-V. ; Heilig, C.E. ; Pirmann, S. ; Hamacher, R. ; Bauer, S. ; Gaidzik, V.I. ; Mayer-Steinacker, R. ; Al-Sabah, J. ; Roldan Pinzon, S.S.L. ; Süße, H. ; Freitag, A. ; Horak, P. ; Kreutzfeldt, S. ; Hutter, B. ; Hüllein, J. ; Sedlaczek, O. ; Lehner, B. ; Egerer, G. ; Jäger, D. ; Müller-Tidow, C. ; Hübschmann, D. ; von Kalle, C. ; Barth, T.F.E. ; Fröhling, S. ; Schlenk, R.F.

In ESMO Open July 2025 10(7)

Möhrmann, L. ; Werner, M. ; Oleś, M. ; Knol, L. ; Arnold, J.S. ; Mundt, T. ; Paramasivam, N. ; Richter, D. ; Fröhlich, M. ; Hutter, B. ; Hüllein, J. ; Jahn, A. ; Scheffold, C. ; Möhrmann, E.E. ; Hanf, D. ; Kreutzfeldt, S. ; Heilig, C.E. ; Teleanu, M.-V. ; Lipka, D.B. ; Beck, K. ; Baude-Müller, A. ; Jelas, I. ; Rieke, D.T. ; Klotz, L.V. ; Shah, R. ; Herold, T. ; Boerries, M. ; Illert, A.L. ; Allgäuer, M. ; Stenzinger, A. ; Kerle, I.A. ; Horak, P. ; Heining, C. ; Schröck, E. ; Hübschmann, D. ; Fröhling, S. ; Glimm, H.

In ESMO Open April 2025 10(4)

Raphael Lutz; Florian Grünschläger; Malte Simon; Mohamed H. S. Awwad; Marcus Bauer; Schayan Yousefian; Niklas Beumer; Lea Jopp-Saile; Anastasia Sedlmeier; Llorenç Solé-Boldo; Bogdan Avanesyan; Dominik Vonficht; Patrick Stelmach; Georg Steinbuss; Tobias Boch; Simon Steiger; Marc-Andrea Baertsch; Nina Prokoph; Karsten Rippe; Brian G. M. Durie; Claudia Wickenhauser; Andreas Trumpp; Carsten Müller-Tidow; Daniel Hübschmann; Niels Weinhold; Marc S. Raab; Benedikt Brors; Hartmut Goldschmidt; Charles D. Imbusch; Michael Hundemer; Simon Haas

Nature Communications, Vol 15, Iss 1, Pp 1-18 (2024)

Proc. of A. Razmadze Math. Inst. 119(1999),59-72

Zuljan E; Core Unit Bioinformatics, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.; von der Emde B; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Piwonski I; Department of Pathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Pestana A; Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité - Universitätsmedizin Berlin, Berlin, Germany.; Klinghammer K; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité - Universitätsmedizin Berlin, Berlin, Germany.; National Center for Tumor Diseases (NCT), NCT Berlin, a partnership between DKFZ, Charité Universitätsmedizin, BIH and MDC, Berlin, Germany.; Mock A; German Cancer Consortium (DKTK), DKFZ, core center Heidelberg, Heidelberg, Germany.; Institute of Pathology, Ludwig-Maximilians-University Munich, München, Germany.; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Horak P; German Cancer Consortium (DKTK), DKFZ, core center Heidelberg, Heidelberg, Germany.; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Heining C; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.; German Cancer Consortium (DKTK), partner site Dresden, Dresden, Germany.; Klauschen F; Department of Pathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité - Universitätsmedizin Berlin, Berlin, Germany.; Institute of Pathology, Ludwig-Maximilians-University Munich, München, Germany.; German Cancer Consortium (DKTK), partner site Munich, Munich, Germany.; Pretzell I; West German Cancer Center, University Hospital Essen, Essen, Germany.; German Cancer Consortium (DKTK), partner site Essen, Essen, Germany.; Boerries M; Institute of Medical Bioinformatics and Systems Medicine, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner site Freiburg, a partnership between DKFZ and Medical Center - University of Freiburg, Freiburg, Germany.; Brandts CH; Goethe University Frankfurt, University Hospital, Department of Medicine, Hematology/Oncology & University Cancer Center Frankfurt (UCT), Frankfurt, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt, Frankfurt, Germany.; Kreutzfeldt S; German Cancer Consortium (DKTK), DKFZ, core center Heidelberg, Heidelberg, Germany.; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Teleanu MV; German Cancer Consortium (DKTK), DKFZ, core center Heidelberg, Heidelberg, Germany.; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Hübschmann D; German Cancer Consortium (DKTK), DKFZ, core center Heidelberg, Heidelberg, Germany.; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Morris LGT; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Heiland M; National Center for Tumor Diseases (NCT), NCT Berlin, a partnership between DKFZ, Charité Universitätsmedizin, BIH and MDC, Berlin, Germany.; Department of Oral and Maxillofacial Surgery, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Keller U; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité - Universitätsmedizin Berlin, Berlin, Germany.; National Center for Tumor Diseases (NCT), NCT Berlin, a partnership between DKFZ, Charité Universitätsmedizin, BIH and MDC, Berlin, Germany.; Conrad T; Genomics Technology Platform, Berlin Institute of Health at Charité - Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Glimm H; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.; German Cancer Consortium (DKTK), partner site Dresden, Dresden, Germany.; Fröhling S; German Cancer Consortium (DKTK), DKFZ, core center Heidelberg, Heidelberg, Germany.; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.; Ochsenreither S; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité - Universitätsmedizin Berlin, Berlin, Germany.; National Center for Tumor Diseases (NCT), NCT Berlin, a partnership between DKFZ, Charité Universitätsmedizin, BIH and MDC, Berlin, Germany.; Keilholz U; Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité - Universitätsmedizin Berlin, Berlin, Germany.; National Center for Tumor Diseases (NCT), NCT Berlin, a partnership between DKFZ, Charité Universitätsmedizin, BIH and MDC, Berlin, Germany.; Blanc E; Core Unit Bioinformatics, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.; Beule D; Core Unit Bioinformatics, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.; Rieke DT; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. damian.rieke@charite.de.; Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. damian.rieke@charite.de.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité - Universitätsmedizin Berlin, Berlin, Germany. damian.rieke@charite.de.; National Center for Tumor Diseases (NCT), NCT Berlin, a partnership between DKFZ, Charité Universitätsmedizin, BIH and MDC, Berlin, Germany. damian.rieke@charite.de.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Jahn, A.; Rump, A.; Widmann, T.J.; Heining, C.; Horak, P.; Hutter, B.; Paramasivam, N.; Uhrig, S.; Gieldon, L.; Drukewitz, S.; Kübler, A.; Bermudez, M.; Hackmann, K.; Porrmann, J.; Wagner, J.; Arlt, M.; Franke, M.; Fischer, J.; Kowalzyk, Z.; William, D.; Weth, V.; Oster, S.; Fröhlich, M.; Hüllein, J.; Valle González, C.; Kreutzfeldt, S.; Mock, A.; Heilig, C.E.; Lipka, D.B.; Möhrmann, L.; Hanf, D.; Oleś, M.; Teleanu, V.; Allgäuer, M.; Ruhnke, L.; Kutz, O.; Knurr, A.; Laßmann, A.; Endris, V.; Neumann, O.; Penzel, R.; Beck, K.; Richter, D.; Winter, U.; Wolf, S.; Pfütze, K.; Geörg, C.; Meißburger, B.; Buchhalter, I.; Augustin, M.; Aulitzky, W.E.; Hohenberger, P.; Kroiss, M.; Schirmacher, P.; Schlenk, R.F.; Keilholz, U.; Klauschen, F.; Folprecht, G.; Bauer, Sebastian; Siveke, Jens; Brandts, C.H.; Kindler, T.; Boerries, M.; Illert, A.L.; von Bubnoff, N.; Jost, P.J.; Metzeler, K.H.; Bitzer, M.; Schulze-Osthoff, K.; von Kalle, C.; Brors, B.; Stenzinger, A.; Weichert, W.; Hübschmann, D.; Fröhling, S.; Glimm, H.; Schröck, E.; Klink, B.

Annals of Oncology. 33:1186-1199

Pixberg, C. ; Zapatka, M. ; Hlevnjak, M. ; Benedetto, S. ; Suppelna, J.P. ; Heil, J. ; Smetanay, K. ; Michel, L. ; Fremd, C. ; Körber, V. ; Rübsam, M. ; Buschhorn, L. ; Heublein, S. ; Schäfgen, B. ; Golatta, M. ; Gomez, C. ; von Au, A. ; Wallwiener, M. ; Wolf, S. ; Dikow, N. ; Schaaf, C. ; Gutjahr, E. ; Allgäuer, M. ; Stenzinger, A. ; Pfütze, K. ; Kirsten, R. ; Hübschmann, D. ; Sinn, H.-P. ; Jäger, D. ; Trumpp, A. ; Schlenk, R. ; Höfer, T. ; Thewes, V. ; Schneeweiss, A. ; Lichter, P.

In ESMO Open December 2022 7(6)

Gehrs S; Division of Vascular Oncology and Metastasis, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Department of Vascular Biology and Tumor Angiogenesis (CBTM), Medical Faculty Mannheim, Heidelberg University, 69120 Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany.; Gu Z; Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Hey J; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Weichenhan D; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Buckwalter N; Division of Vascular Oncology and Metastasis, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Department of Vascular Biology and Tumor Angiogenesis (CBTM), Medical Faculty Mannheim, Heidelberg University, 69120 Heidelberg, Germany.; Jakab M; Division of Vascular Oncology and Metastasis, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Department of Vascular Biology and Tumor Angiogenesis (CBTM), Medical Faculty Mannheim, Heidelberg University, 69120 Heidelberg, Germany.; Hotz-Wagenblatt A; Core Facility Omics IT and Data Management (ODCF), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Breuer K; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Prada ML; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Hübschmann D; Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Innovation and Service Unit for Bioinformatics and Precision Medicine (BPM), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Pattern Recognition and Digital Medicine Group (PRDM), Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM) gGmbH, 69120 Heidelberg, Germany.; German Cancer Consortium (DKTK), 69120 Heidelberg, Germany.; Schlereth K; Division of Vascular Oncology and Metastasis, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Department of Vascular Biology and Tumor Angiogenesis (CBTM), Medical Faculty Mannheim, Heidelberg University, 69120 Heidelberg, Germany.; Plass C; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Augustin H; Division of Vascular Oncology and Metastasis, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Department of Vascular Biology and Tumor Angiogenesis (CBTM), Medical Faculty Mannheim, Heidelberg University, 69120 Heidelberg, Germany.

Publisher: Oxford University Press Country of Publication: England NLM ID: 0411011 Publication Model: Print Cited Medium: Internet ISSN: 1362-4962 (Electronic) Linking ISSN: 03051048 NLM ISO Abbreviation: Nucleic Acids Res Subsets: MEDLINE

Nichetti F; Oncology Unit 1, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy. federico.nichetti@iov.veneto.it.; Computational Oncology, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany. federico.nichetti@iov.veneto.it.; Hüllein J; Computational Oncology, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; du Rusquec P; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France.; INSERM U900 Research unit, Institut Curie, Saint-Cloud, France.; Pleasance E; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.; Chen L; Division of Cancer Biostatistics, Department of Internal Medicine, University of Kentucky, Lexington, KY, USA.; Markey Cancer Center, University of Kentucky, Lexington, KY, USA.; Mock A; Institute of Pathology, University of Munich (LMU), Munich, Germany.; Horak P; German Cancer Consortium (DKTK), Heidelberg, Germany.; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Ambrosini P; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.; Rota S; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.; Niger M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.; Agnelli L; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.; Tinè G; Biostatistics for Clinical Research Unit, Epidemiology and Data Science Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy.; Edelmann D; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; NCT Trial Center, National Center for Tumor Diseases, Heidelberg, Germany.; Le Tourneau C; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France.; INSERM U900 Research unit, Institut Curie, Saint-Cloud, France.; Paris-Saclay University, Paris, France.; Laskin J; Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.; Pruneri G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Wang C; Division of Cancer Biostatistics, Department of Internal Medicine, University of Kentucky, Lexington, KY, USA.; Markey Cancer Center, University of Kentucky, Lexington, KY, USA.; Hübschmann D; Computational Oncology, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Pattern Recognition and Digital Medicine Group, Heidelberg Institute for Stem cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany.; de Braud F; Oncology Unit 1, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Fröhling S; German Cancer Consortium (DKTK), Heidelberg, Germany.; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Mariani L; Biostatistics for Clinical Research Unit, Epidemiology and Data Science Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy.

Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE

Till A; Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany. andreas.till@bfarm.de.; Siddiqui RA; Technology, Methods, and Infrastructure for Networked Medical Research (TMF), Berlin, Germany.; Altbürger C; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Center for Personalized Medicine (ZPM) Heidelberg, Heidelberg, Germany.; Schwarz R; National Association of Statutory Health Insurance Funds, GKV-Spitzenverband, Berlin, Germany.; Huebner T; Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany.; Wolf J; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), University Hospital of Cologne, Cologne, Germany.; National Network Genomic Medicine (nNGM) Lung Cancer, University Hospital of Cologne, Cologne, Germany.; Andres D; Federal Ministry of Health, Bonn, Germany.; Anker A; Federal Ministry of Health, Bonn, Germany.; Aretz S; Institute of Human Genetics, University Hospital Bonn, Bonn, Germany.; Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany.; European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS), Bonn, Germany.; Haack TB; Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tubingen, Germany.; Center for Rare Diseases, University of Tübingen, Tubingen, Germany.; Berlage T; Fraunhofer Institute for Applied Information Technology FIT, Sankt Augustin, Germany.; RWTH Aachen University, Aachen, Germany.; Beule D; Berlin Institute of Health, Translational Research Unit of Charité-Universitätsmedizin Berlin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Boerries M; Institute of Medical Bioinformatics and Systems Medicine, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg (a partnership between DKFZ and Medical Center-University of Freiburg), Freiburg, Germany.; Buchhalter I; Omics IT and Data Management Core Facility, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Bussmann J; German Association of Academic Medical Centers (Verband der Universitätsklinika Deutschlands), Berlin, Germany.; Engel C; Institute for Medical Informatics, Statistics and Epidemiology, Leipzig University, Leipzig, Germany.; Friedrichs J; House of Cancer Self-Help - Federal Association, Bonn, Germany.; Fröhling S; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg (a partnership between DKFZ and Heidelberg University Hospital), Heidelberg, Germany.; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany.; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.; Haenisch B; Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany.; Center for Translational Medicine, University of Bonn, Bonn, Germany.; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.; Hahne A; BRCA Network-Help for People affected by Hereditary Cancer, Bonn, Germany.; Hübschmann D; National Center for Tumor Diseases (NCT), NCT Heidelberg (a partnership between DKFZ and Heidelberg University Hospital), Heidelberg, Germany.; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany.; BRCA Network-Help for People affected by Hereditary Cancer, Bonn, Germany.; Innovation and Service Unit for Bioinformatics and Precision Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Heidelberg Institute for Stem cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany.; von Kessel F; Technology, Methods, and Infrastructure for Networked Medical Research (TMF), Berlin, Germany.; Klatt R; Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany.; Kreutzfeldt S; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg (a partnership between DKFZ and Heidelberg University Hospital), Heidelberg, Germany.; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany.; Kron A; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), University Hospital of Cologne, Cologne, Germany.; National Network Genomic Medicine (nNGM) Lung Cancer, University Hospital of Cologne, Cologne, Germany.; Krude H; Institute of Experimental Pediatric Endocrinology, Charite-Universitätsmedizin, Berlin, Germany.; Lübbe A; Robert Koch Institute, Berlin, Germany.; Lührig U; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), University Hospital of Cologne, Cologne, Germany.; National Network Genomic Medicine (nNGM) Lung Cancer, University Hospital of Cologne, Cologne, Germany.; Malek N; Department for Internal Medicine 1, M3-Research Center for Malignome, Metabolome and Microbiome, University Hospital Tübingen, Tubingen, Germany.; Center for Personalized Medicine Tübingen, University Hospital Tübingen, Tubingen, Germany.; Mertes C; TUM School of Computation, Information and Technology, Technical University of Munich, Garching, Germany.; Institute of Human Genetics, School of Medicine, Technical University of Munich, Munich, Germany.; Möller Y; Center for Personalized Medicine Tübingen, University Hospital Tübingen, Tubingen, Germany.; M3-Research Center for Malignome, Metabolome and Microbiome, University Hospital Tübingen, Tubingen, Germany.; Mundlos C; Alliance for Chronic Rare Diseases Germany (ACHSE), DRK Klinikum Berlin Mitte, Berlin, Germany.; Nöthen MM; Institute of Human Genetics, University Hospital Bonn, Bonn, Germany.; Ossowski S; Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tubingen, Germany.; Center for Personalized Medicine Tübingen, University Hospital Tübingen, Tubingen, Germany.; Institute for Bioinformatics and Medical Informatics (IBMI), University of Tübingen, Tubingen, Germany.; Pötschke L; Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany.; Rasokat A; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), University Hospital of Cologne, Cologne, Germany.; National Network Genomic Medicine (nNGM) Lung Cancer, University Hospital of Cologne, Cologne, Germany.; Riess O; Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tubingen, Germany.; Center for Rare Diseases, University of Tübingen, Tubingen, Germany.; Schade S; Federal Ministry of Health, Bonn, Germany.; Schirmacher P; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Center for Personalized Medicine (ZPM) Heidelberg, Heidelberg, Germany.; Schmutzler R; Faculty of Medicine, University of Cologne and Center for Familial Breast and Ovarian Cancer, University Hospital Cologne, Cologne, Germany.; German Consortium Hereditary Breast and Ovarian Cancer (GC-HBOC), University Hospital of Cologne, Cologne, Germany.; Scholl C; Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany.; Semler SC; Technology, Methods, and Infrastructure for Networked Medical Research (TMF), Berlin, Germany.; Spielmann M; Institute of Human Genetics, University Hospital Schleswig-Holstein, University of Lübeck and Kiel University, Lubeck, Germany.; Stegle O; Division of Computational Genomics & Systems Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; European Biology Laboratory (EMBL), Genome Biology Unit, Heidelberg, Germany.; Stenzinger A; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Center for Personalized Medicine (ZPM) Heidelberg, Heidelberg, Germany.; Straßburger J; Federal Ministry of Health, Bonn, Germany.; Schröck E; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden, University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden, Germany.; Krawczak M; Technology, Methods, and Infrastructure for Networked Medical Research (TMF), Berlin, Germany.; Institute of Medical Informatics and Statistics, Kiel University, University Medical Center Schleswig-Holstein, Kiel, Germany.; Kohlbacher O; Center for Personalized Medicine Tübingen, University Hospital Tübingen, Tubingen, Germany. oliver.kohlbacher@uni-tuebingen.de.; Institute for Bioinformatics and Medical Informatics (IBMI), University of Tübingen, Tubingen, Germany. oliver.kohlbacher@uni-tuebingen.de.; Department of Computer Science, University of Tübingen, Tubingen, Germany. oliver.kohlbacher@uni-tuebingen.de.; Institute for Translational Bioinformatics, University Hospital Tübingen, Tubingen, Germany. oliver.kohlbacher@uni-tuebingen.de.

Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: In Process; MEDLINE

Heilig, C.E. ; Horak, P. ; Kreutzfeldt, S. ; Teleanu, V. ; Mock, A. ; Renner, M. ; Bhatti, I.A. ; Hutter, B. ; Hüllein, J. ; Fröhlich, M. ; Uhrig, S. ; Süße, H. ; Heiligenthal, L. ; Ochsenreither, S. ; Illert, A.L. ; Vogel, A. ; Desuki, A. ; Heinemann, V. ; Heidegger, S. ; Bitzer, M. ; Scheytt, M. ; Brors, B. ; Hübschmann, D. ; Baretton, G. ; Stenzinger, A. ; Steindorf, K. ; Benner, A. ; Jäger, D. ; Heining, C. ; Glimm, H. ; Fröhling, S. ; Schlenk, R.F.

In ESMO Open December 2021 6(6)

E. Rempel; K. Kluck; S. Beck; I. Ourailidis; D. Kazdal; O. Neumann; A. L. Volckmar; M. Kirchner; H. Goldschmid; N. Pfarr; W. Weichert; D. Hübschmann; S. Fröhling; C. Sutter; C. P. Schaaf; P. Schirmacher; V. Endris; A. Stenzinger; J. Budczies

npj Precision Oncology, Vol 6, Iss 1, Pp 1-13 (2022)

Hlevnjak M; Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Heublein S; Department of Gynecology and Obstetrics, University Hospital Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany.; Thewes V; National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Wagener L; National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Pixberg C; National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Fremd C; National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Michel L; National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Maurer C; National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Buschhorn L; National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Dikow N; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.; Feng F; Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Fröhling S; National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Herold-Mende C; Division of Experimental Neurosurgery, Department of Neurosurgery, Medical Faculty Heidelberg, University of Heidelberg, Heidelberg, Germany.; Hirsch S; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.; Hopp Children's Cancer Center Heidelberg (KiTZ), Division of Pediatric Neurooncology, DKFZ; German Cancer Consortium (DKTK), Partner Site Heidelberg, Heidelberg, Germany.; Hong C; Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Hübschmann D; National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Jassowicz L; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Experimental Neurosurgery, Department of Neurosurgery, Medical Faculty Heidelberg, University of Heidelberg, Heidelberg, Germany.; Kozyulina P; Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Pfütze K; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Experimental Neurosurgery, Department of Neurosurgery, Medical Faculty Heidelberg, University of Heidelberg, Heidelberg, Germany.; Sample Processing Laboratory, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Schlenk RF; Department of Medical Oncology, National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; NCT Clinical Trial Center, National Center for Tumor Diseases (NCT), NCT Heidelberg a Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the HeidelbergUniversity, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Department of Internal Medicine V, University Hospital, Heidelberg, Germany.; Sinn HP; Institute for Pathology, University Hospital Heidelberg, Heidelberg, Germany.; Smetanay K; Department of Gynecology and Obstetrics, University Hospital Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Springfeld C; Department of Medical Oncology, National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Stenzinger A; Institute for Pathology, University Hospital Heidelberg, Heidelberg, Germany.; Wagner C; National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Department of Obstetrics and Gynecology, University Hospital, LMU, Munich, Germany.; Wolf S; Next Generation Sequencing Core Facility, German Cancer Research Center DKFZ, Heidelberg, Germany.; Trumpp A; German Cancer Consortium (DKTK), Heidelberg, Germany.; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Jäger D; Department of Medical Oncology, National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Zivanovic O; Department of Gynecology and Obstetrics, University Hospital Heidelberg, Heidelberg, Germany.; Zapatka M; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Schneeweiss A; National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Lichter P; National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ, The University Hospital Heidelberg (UKHD), The Heidelberg Medical Faculty of the Heidelberg University, and The Thorax Clinic Heidelberg, Heidelberg, Germany.; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

Lutz R; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany.; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Poos AM; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Solé-Boldo L; Berlin Institute of Health (BIH) at Charité Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Berlin, Germany.; Precision Healthcare University Research Institute, Queen Mary University of London, London, UK.; John L; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Wagner J; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Prokoph N; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Baertsch MA; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Vonficht D; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany.; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Palit S; Berlin Institute of Health (BIH) at Charité Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Berlin, Germany.; Brobeil A; Department of Pathology, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Tissue Bank of the National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.; Mechtersheimer G; Department of Pathology, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Hildenbrand N; Department of Orthopaedics, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Hemmer S; Department of Orthopaedics, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Steiger S; Division of Chromatin Networks, German Cancer Research Center (DKFZ) and BioQuant, Heidelberg, Germany.; Horn S; Berlin Institute of Health (BIH) at Charité Universitätsmedizin Berlin, Berlin, Germany.; Institute of Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Pepke W; Department of Orthopaedics, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Spranz DM; Department of Orthopaedics, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Rehnitz C; Department of Radiology, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Sant P; Single Cell Open Lab, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Mallm JP; Single Cell Open Lab, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Friedrich MJ; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Reichert P; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Huhn S; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Trumpp A; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany.; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Rippe K; Division of Chromatin Networks, German Cancer Research Center (DKFZ) and BioQuant, Heidelberg, Germany.; Haghverdi L; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Fröhling S; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.; Müller-Tidow C; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Hübschmann D; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Computational Oncology, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Goldschmidt H; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; GMMG-Study Group at Heidelberg University Hospital, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Willimsky G; Berlin Institute of Health (BIH) at Charité Universitätsmedizin Berlin, Berlin, Germany.; Institute of Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, Berlin, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Sauer S; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Raab MS; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Haas S; Berlin Institute of Health (BIH) at Charité Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Berlin, Germany.; Precision Healthcare University Research Institute, Queen Mary University of London, London, UK.; German Cancer Consortium (DKTK), partner site Berlin, Berlin, Germany.; Weinhold N; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University and German Cancer Research Center (DKFZ), Heidelberg, Germany.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101688624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2470-9468 (Electronic) Linking ISSN: 24709468 NLM ISO Abbreviation: Sci Immunol Subsets: MEDLINE

Hübschmann D; Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between the German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Heidelberg, Germany. d.huebschmann@dkfz-heidelberg.de.; Pattern Recognition and Digital Medicine Group, Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany. d.huebschmann@dkfz-heidelberg.de.; German Cancer Consortium (DKTK), DKFZ, Core Center Heidelberg, Heidelberg, Germany. d.huebschmann@dkfz-heidelberg.de.; Innovation and Service Unit for Bioinformatics and Precision Medicine, DKFZ, Heidelberg, Germany. d.huebschmann@dkfz-heidelberg.de.; Institute of Human Genetics, Heidelberg University Hospital, Heidelberg, Germany. d.huebschmann@dkfz-heidelberg.de.; Kreutzfeldt S; German Cancer Consortium (DKTK), DKFZ, Core Center Heidelberg, Heidelberg, Germany.; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany.; Roth B; Secondary Use of Data in Oncology Group, Clinical Trial Office, DKFZ, Heidelberg, Germany.; Glocker K; Secondary Use of Data in Oncology Group, Clinical Trial Office, DKFZ, Heidelberg, Germany.; Medical Genetics Center, Munich, Germany.; Schoop J; Secondary Use of Data in Oncology Group, Clinical Trial Office, DKFZ, Heidelberg, Germany.; Oeser L; Secondary Use of Data in Oncology Group, Clinical Trial Office, DKFZ, Heidelberg, Germany.; Hausmann S; Secondary Use of Data in Oncology Group, Clinical Trial Office, DKFZ, Heidelberg, Germany.; Koch C; Secondary Use of Data in Oncology Group, Clinical Trial Office, DKFZ, Heidelberg, Germany.; Uhrig S; Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between the German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Heidelberg, Germany.; Hüllein J; Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between the German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Heidelberg, Germany.; Hutter B; Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between the German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Heidelberg, Germany.; Fröhlich M; Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between the German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Heidelberg, Germany.; Heilig CE; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany.; Teleanu MV; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany.; Lipka DB; German Cancer Consortium (DKTK), DKFZ, Core Center Heidelberg, Heidelberg, Germany.; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany.; Kerle IA; Department of Translational Medical Oncology, NCT, NCT/University Cancer Center (NCT/UCC) Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.; DKTK, Partner Site Dresden, Dresden, Germany.; Baude-Müller A; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany.; Beck K; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany.; Heining C; Department of Translational Medical Oncology, NCT, NCT/University Cancer Center (NCT/UCC) Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.; DKTK, Partner Site Dresden, Dresden, Germany.; Glimm H; Department of Translational Medical Oncology, NCT, NCT/University Cancer Center (NCT/UCC) Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.; DKTK, Partner Site Dresden, Dresden, Germany.; Ückert F; Institute for Applied Medical Informatics, Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Knurr A; Secondary Use of Data in Oncology Group, Clinical Trial Office, DKFZ, Heidelberg, Germany.; Fröhling S; German Cancer Consortium (DKTK), DKFZ, Core Center Heidelberg, Heidelberg, Germany. stefan.froehling@nct-heidelberg.de.; Institute of Human Genetics, Heidelberg University Hospital, Heidelberg, Germany. stefan.froehling@nct-heidelberg.de.; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany. stefan.froehling@nct-heidelberg.de.; Horak P; German Cancer Consortium (DKTK), DKFZ, Core Center Heidelberg, Heidelberg, Germany. peter.horak@nct-heidelberg.de.; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany. peter.horak@nct-heidelberg.de.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Zech HB; Department of Otorhinolaryngology, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.; Mildred-Scheel Cancer Career Center HaTriCS4, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.; Schafhausen P; 2nd Department of Medicine (Oncology, Hematology, Bone Marrow Transplantation with Section Pneumology) and University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.; Ramke L; Department of Otorhinolaryngology, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.; Velthaus JL; 2nd Department of Medicine (Oncology, Hematology, Bone Marrow Transplantation with Section Pneumology) and University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.; Kreutzfeldt S; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a Partnership Between German Cancer Research Center (DKFZ) and Heidelberg University Hospital, 01307 Heidelberg, Germany.; Hübschmann D; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a Partnership Between German Cancer Research Center (DKFZ) and Heidelberg University Hospital, 01307 Heidelberg, Germany.; German Cancer Consortium (DKTK), Core Center Heidelberg, 69120 Heidelberg, Germany.; Institute of Human Genetics, Heidelberg University, 69120 Heidelberg, Germany.; Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Innovation and Service Unit for Bioinformatics and Precision Medicine, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Pattern Recognition and Digital Medicine Group, Heidelberg Institute for Stem Cell Technology and Experimental Medicine, 69120 Heidelberg, Germany.; Rothkamm K; Department of Radiotherapy & Radiation Oncology, Hubertus Wald Tumorzentrum-University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.; Bokemeyer C; 2nd Department of Medicine (Oncology, Hematology, Bone Marrow Transplantation with Section Pneumology) and University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.; Hoffmann AS; Department of Otorhinolaryngology, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.; Fröhling S; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a Partnership Between German Cancer Research Center (DKFZ) and Heidelberg University Hospital, 01307 Heidelberg, Germany.; German Cancer Consortium (DKTK), Core Center Heidelberg, 69120 Heidelberg, Germany.; Institute of Human Genetics, Heidelberg University, 69120 Heidelberg, Germany.; Glimm H; Department of Translational Medical Oncology, NCT, NCT/University Cancer Center Dresden, a Partnership Between German Cancer Research Center (DKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus, Dresden University of Technology (TUD), and Helmholtz-Zentrum Dresden-Rossendorf, 01307 Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD, 01069 Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, 01307 Dresden, Germany.; Translational Functional Cancer Genomics, German Cancer Consortium (DKFZ), 69120 Heidelberg, Germany.; Betz CS; Department of Otorhinolaryngology, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.; Kriegs M; Department of Radiotherapy & Radiation Oncology, Hubertus Wald Tumorzentrum-University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.; UCCH Kinomics Core Facility, Hubertus Wald Tumorzentrum-University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.; Christopeit M; 2nd Department of Medicine (Oncology, Hematology, Bone Marrow Transplantation with Section Pneumology) and University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.

Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101691304 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9059 (Print) Linking ISSN: 22279059 NLM ISO Abbreviation: Biomedicines Subsets: PubMed not MEDLINE

Josefine Radke; Naveed Ishaque; Randi Koll; Zuguang Gu; Elisa Schumann; Lina Sieverling; Sebastian Uhrig; Daniel Hübschmann; Umut H. Toprak; Cristina López; Xavier Pastor Hostench; Simone Borgoni; Dilafruz Juraeva; Fabienne Pritsch; Nagarajan Paramasivam; Gnana Prakash Balasubramanian; Matthias Schlesner; Shashwat Sahay; Marc Weniger; Debora Pehl; Helena Radbruch; Anja Osterloh; Agnieszka Korfel; Martin Misch; Julia Onken; Katharina Faust; Peter Vajkoczy; Dag Moskopp; Yawen Wang; Andreas Jödicke; Lorenz Trümper; Ioannis Anagnostopoulos; Dido Lenze; Ralf Küppers; Michael Hummel; Clemens A. Schmitt; Otmar D. Wiestler; Stephan Wolf; Andreas Unterberg; Roland Eils; Christel Herold-Mende; Benedikt Brors; ICGC MMML-Seq Consortium; Reiner Siebert; Stefan Wiemann; Frank L. Heppner

Nature Communications, Vol 13, Iss 1, Pp 1-20 (2022)